Key facts
- Notable investors include Samsara BioCapital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Alentar Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Alentar Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alentar Biosciences
Developer of therapeutic agents designed for the purpose of reversing goblet cell hyperplasia in patients with cystic fibrosis and other pulmonary conditions. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Ownership
- Privately Held (backing)
Alentar Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alentar Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alentar Biosciences in its N-PORT filings yet. We sweep new filings monthly.